The key to defeating drug resistance, whether it be bacteria, fungi, viruses, or cancer cells, is developing compounds with new mechanisms of action. By exploiting novel protein targets and new natural environments, CFD Biosciences is advancing candidates to treat multi-drug resistant microbes and cancers.
Antimicrobial Natural Products
Utilizing extremophiles and metagenomics, CFD Biosciences created an unprecedented natural products mining platform – EMAD
(extremophilic microbiome antimicrobial discovery).
Cancer Therapeutics
Based on novel crystal structures and virtual screening, new potent inhibitors have been discovered which are effective against multi-drug resistant pancreatic cancer cells.
Pipeline
Targeted Therapeutics
CFD Biosciences is committed to developing drugs with fewer off-target effects (side effects). We focus on specific pathogenic microbes – leaving the microbiome intact. We focus on the most severe cancer subtypes – leaving your normal cells healthy.